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ABSTRACT
￿
We have observed a striking differential effect of the ionophore, monensin, on replication
of influenza virus and vesicular stomatitis virus (VSV) in Madin-Darby canine kidney (MDCK) and
baby hamster kidney (BHK21) cells. In MDCK cells, influenza virus is assembled at the apical surfaces,
whereas VSV particles bud from the basolateral membranes; no such polarity of maturation is
exhibited in BHK21 cells. A 10-6 M concentration of monensin reduces VSV yields in MDCK cells by
>90% as compared with controls, whereas influenza virus yields are unaffected . In BHK21 cells,
monensin also inhibits VSV production, but influenza virus is also sensitive to the ionophore.
Immunofluorescent staining of fixed and unfixed MDCK monolayers indicates that VSV glycoproteins
are synthesized in the presence of monensin, but their appearance on the plasma membrane is
blocked. Electron micrographs of VSV-infected MDCK cells treated with monensin show VSV particles
aggregated within dilated cytoplasmic vesicles. Monensin-treated influenza virus-infected MDCK
cells also contain dilated cytoplasmic vesicles, but virus particles were not found in these structures,
and numerous influenza virions were observed budding at the cell surface . These results indicate that
influenza virus glycoprotein transport is not blocked by monensin treatment, whereas there is a block
in transport of VSV G protein . Thus it appears that at least two distinct pathways of transport of
glycoproteins to the plasma membrane exist in MDCK cells, and only one of them is blocked by
monensin.
Ionophores that have an affinity for monovalent cations were
previously shown to block the secretion of proteins and glyco-
proteins in a variety ofeukaryotic cells(6, 16, 17, 19). Inhibition
of the release of procollagen and fibronectin from human
fibroblasts by monovalent ionophores has been reported (6,
19), as well as an arrest in plasma cell immunoglobulin secre-
tion (17). The inhibition of secretion by monensin, a linear
polyether with a high affinity for Na' ions (9), is accompanied
by a pronounced morphological change in the Golgi apparatus,
with accumulation of dilated cytoplasmic vacuoles (16, 19). It
has been proposed that monensin affects intracellular transport
at the level of the Golgi complex by blocking the release of
secretory vesicles from Golgi membranes that become dilated
as a result of the drug (17).
Cells of the Madin-Darby canine kidney (MDCK) line form
monolayers with features of normal epithelia, including a
spontaneous electricalpotential as well as a net water flux from
apical to basal surfaces (1, 8, 10). The cells exhibit junctional
complexes that delineate two distinct membrane domains, the
apical surfaces characterized by microvilli, and the basolateral
surfaces that relate to the basal lamina and to other adjacent
cells (1, 12). It has been reported that influenza virus buds
exclusively at free apical surfaces of MDCK cells, whereas
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vesicular stomatitis virus (VSV) matures only at the basolateral
membranes (12). This polarity of virus maturation does not
require glycosylation of viralglycoproteins (14) but it is likely
that the site ofinsertion of viral glycoproteins into the plasma
membrane determines the virus maturation site, because viral
glycoproteins are localized in the same membrane domain
where budding occurs (11). These findings suggested that
distinct pathways for transport ofmembrane glycoproteins may
exist in MDCK cells. Monensin was recently found to block
the transport of glycoproteins of VSV and Sindbis virus to the
plasma membrane in chicken embryo fibroblast and baby
hamster kidney (BHK21) cells (4, 5). Because of the previous
results indicating that different pathways are involved in trans-
port of VSV and influenza virus glycoproteins to cell surfaces,
we sought to determine whether the replication of influenza
virus and VSV can be differentially affected by monensin.
MATERIALS AND METHODS
Materials
Newborn calf serum was obtained from Biocell Laboratories, Carson, Calif .
Monensin was purchased from Calbiochern-Behring Corp., American Hoechst
Corp., La Jolla, Calif .
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MDCK and Madin-Darby bovine kidney (MDBK) cells were grown as
previously described (13). MDCK cells were maintained in medium supple-
mented with 5% newborn calf serum. BHK21 cells were grown by described
procedures (3). All cells were grown at 37'C in an atmosphere of 5% C02 in air.
Stocks of the A/WSN (HoN,) strain of influenza virus were prepared in
MDBK cells (2), and VSV stocks were grown in BHK21 cells (13). Influenza
virus infectivity titers were assayed by plaquing on MDCK cells as previously
described (13), except that monolayers were grown on 22.6-mm l2-well culture
plates and were inoculated with 0.1 ml ofvirus dilutions. Infectivity titers ofVSV
were measured by plaguing on BHK21 cells (l3).
Treatment with Monensin
Stock solutions of monensin were prepared in absolute ethanol. Confluent
MDCK and BHK21 cells in 60-mm dishes were washed twice with phosphate-
buffered saline (PBS) and infected with 10 plaque-forming units (pfu) per cell of
either influenza virus or VSV. The adsorption period for influenza virus was 2 h
at 37°C, whereas VSV adsorption was 1 h at room temperature. Various
concentrations of monensin in serum-free Dulbecco's modified Eagle's medium
were added postadsorption. For controls, equivalent concentrations of absolute
ethanol were added. Virus yields were determined at 24hpostinfection by plaque
assays.
Immunofluorescence
Rhodamine-conjugated rabbit anti-VSV G protein IgG was a gift from M.
Roth, and was prepared as described by Winchester (20). VSV-infected MDCK
cells (multiplicity of infection [MOI] = l) grown on cover slips were treated
postadsorption with 10-5 M monensin as described above. For examination of
surface antigens, cells were washed with PBS and treated with 30 mM EGTA in
Cat'-free Eagle's minimal essential medium for 25 min at 37°C. When most cells
had rounded up, monolayers were extensively washed with PBS containing 1%
bovine serum albumin and 0.03% sodium azide (PBS-BSA), and rhodamine-
tagged antiserum was added for 1 h at room temperature. The cells were then
washed thoroughly before mounting on glass microscope slides in a 1:1 solution
ofglycerol and PBS-BSA. For examination ofintracellular antigens, cover slips
ofcells were fixed in 95%ethanol/5% acetic acid for 20minat -20°C, and stored
overnight in PBS-BSA at 4°Cbefore staining for 30 minat room temperature as
above. Cells were viewed with an American Optical microscope and photo-
graphed with Kodak Ektachrome 200 daylight film.
Electron Microscopy
MDCK cells grown in 60-mm dishes were infected with a multiplicity of 10
pfu/cell for influenza viruses or 50 pfu/cell for VSV, and treated with monensin
as described above. At intervals postinfection, cells were washed three times with
PBSand fixed in situ overnight with 1% glutaraldehyde in PBS. Monolayers were
postfixed with 2% osmium tetroxide for 30 min, and dehydrated with 70, 95, and
100% ethanol. The cells were removed as a sheet from their plastic substrate by
addition of propylene oxide, and embedded in an epoxy resin mixture. Thin
sections were cut on a Sorvall MT2B ultramicrotome (DuPont Company,
Biomedical Products Div., Wilmington, Del.), mounted on 300-mesh copper
grids, stained with uranyl acetate and lead citrate, and examined in a Philips 301
electron microscope.
RESULTS
A striking difference was found between the effect ofmonensin
on the yields of infectious influenza viruses and VSV from
infected MDCK cells. As shown in Fig. 1, the infectivity titers
of VSV were markedly decreased with increasing concentra-
tions of monensin. At a 10-s M monensin concentration, the
yield of VSV plaque-forming units was reduced by >90%, and
a reduction of >I04 in infectious virus yield was obtained with
the highest concentration of monensin tested (10-4 M). In
contrast, monensin had little or no effect on influenza virus
yields in parellel experiments. At a 10-6 M concentration of
monensin, the virus titer obtained was similar to that from the
control cells. Even at a 10-4 M monensin concentration, a less
than threefold decrease in yield of infectious influenza virus
was obtained.
To determine whether virus replication was differentially
affected in another cell line that does not exhibit polarity of
virus maturation, we examined the effects of monensin on
yields ofVSV and influenza virus from BHK21 fibroblasts. As
seen in Fig. 2, replication of VSV was again found to be very
sensitive to the presence of the ionophore. VSV yields were
reduced by >99% in the presence of 10-5 M monensin, and a
reduction of - 105 was observed in the VSV yield in the
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FIGURE 1
￿
Effect of monensin on the yields of infectious influenza
virus and VSV in MDCK cells. Monensin was added postadsorption
to confluent MDCK monolayers infected with 10 plaque-forming
units (pfu) per cell of influenza virus or VSV. Culture fluids were
harvested 24 h postinfection. Infectivity titers were determined by
plaque assays on MDCK cell for influenza virus and on BHK21 cells
for VSV. Influenza virus titers ("), VSV infectivity titers (").
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FIGURE 2
￿
Effect of monensin on yields of influenza virus and VSV
from BHK21 cells. Confluent BHK21 cell monolayers were infected
with 10 pfu per cell of influenza virus or VSV, and monensin was
added postadsorption. After 24 h, virus yields were measured by
plaque assays. Because influenza virus infectivity titers are usually
much lower than that of VSV from BHK21 cells, the results are
plotted as percent of control titers to facilitate comparison. Influenza
virus titers ("), VSV infectivity titers ("). At the 100% point, the
influenza virus infectivity titer was 9.2 X 107 pfu/ml and the VSV
titer was 1 .0 X 10" pfu/ml.
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Hpresence of 10-"M monensin . Influenza virus yields were also
reduced significantly in this cell line, particularly when high
concentrations of the ionophore were used . It is possible that
the ionophore has toxic effects on this cell line in the higher
concentration ranges used.
The preceding data, together with previous observations (4,
17, 19), suggest that monensin blocks the transport of VSV
glycoproteins to plasma membranes in MDCK and BHK21
cells . We used immunofluorescence to determine whether the
VSV glycoprotein is present at the surface of monensin-treated
cells . At 9 h postinfection, VSV-infected MDCK cells incu-
bated in the presence or absence of monensin were stained
with rhodamine-conjugated anti-VSV G protein IgG . Mono-
layers of both treated and untreated cells made permeable to
antibodies by alcohol-acetic acid fixation showed bright fluo-
rescence in the perinuclear area (Fig . 3) . Whereas areas along
the plasma membrane of untreated cells also displayed some
fluorescence, this was not evident in the presence of monensin .
For detection of surface antigens, EGTA was added to unfixed
monolayers before the antibody conjugate; this treatment
causes cells to round up and thus enables the antibodies to
reach the basolateral surfaces ofMDCK cells, where the assem-
bly ofVSV particles occurs. A brilliant fluorescence was ob-
served along the plasma membrane of cells not treated with
monensin (Fig . 3 C), whereas monensin-treated cells showed
no fluorescence above background levels (Fig. 3 D) . These
results indicate that VSV G protein is synthesized but is not
transported to the cell surface in the presence of monensin .
Influenza viral antigens were readily observed, however, on
surfaces of monensin-treated cells (not shown) . In other exper-
iments, we have also demonstrated the synthesis of all major
VSV proteins in monensin-treated cells by analysis using SDS
polyacrylamide gel electrophoresis (not shown) .
The difference in effect of monensin on replication ofVSV
and influenza virus was also clearly evident when thin sections
of infected cells were examined by electron microscopy . VSV-
infected MDCK cells treated with 10-5M monensin contained
dilated cytoplasmic vesicles, similar to the structures previously
described in other monensin-treated cells (5, 17) . In most cells,
these vesicles were localized near the basolateral surfaces. In
some instances, these cytoplasmic vesicles contained VSV par-
ticles and other electron-dense material (Fig . 4) . Virions were
rarely seen forming at the basolateral membrane .
Numerous dilated cytoplasmic vesicles were also observed
FIGURE 3
￿
Localization of VSV G protein in infected MDCK cells . Cells were infected withVSVand examined by immunofluores-
cence at 9 h postinfection as described in Materials and Methods. For localization of intracellular antigen, cells were made
permeable by alcohol-acetic acid fixation . (A) Fixed cells, not treated with monensin . (t3) Fixed cells, treated with 10-5 M
monensin . (C) Unfixed cells, not treated with monensin . (D) Unfixed cells, treated with monensin . x 1,100 .
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￿
VSV-infected MDCK monolayers treated with 10-5 M monensin (MOI = 50) . (A) Low magnification view of a cell at
9 h postinfection showing cytoplasmic vesicles containing viral components (arrows) . The basolateral membranes are free of
budding VSV virions . x 27,000. (8) A cytoplasmic vesicle shown at high magnification containing numerous VSV particles and
some additional electron-dense material . A particle lying longitudinally is indicated by an arrow . x 75,000 .
in influenza virus-infected MDCK cells treated with 10-5M
monensin (Fig. 5) . However, no influenza virions were ob-
served within these structures. Numerous influenza virions
were found budding at the free apical surfaces, as seen in
infected MDCK cells not treated with monensin. In some
instances, some virus particles were observed at the basolateral
membrane as well ; however, this was also observed when
controls not treated with monensin were examined at similar
time-points, indicating that strict polarity ofmaturation is lost
at later times postinfection .
DISCUSSION
The present results demonstrate that the pathways of transport
and insertion of influenza virus and VSV glycoproteins into
the plasma membrane of MDCK cells differ with respect to
monensin sensitivity . Infectivity titers of VSV are markedly
reduced upon treatment of VSV-infected cells with monensin,
although all viral proteins are synthesized . The G protein,
however, does not appear to reach the cell surface, as was also
observed by Johnson and Schlesinger (4) in two other cell
types . Surprisingly, influenza virus yields in MDCK cells were
unaffected or only slightly affected at the same concentrations
of monensin . The difference in effect of monensin on replica-
tion of influenza virus and VSV was also apparent when
infected cells were examined by electron microscopy . In VSV-
infected MDCK cells treated with monensin, virus particles
were observed within dilated vacuoles. These cytoplasmic
structures are very similar to those found in other monensin-
RAPID COMMUNICATIONS
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￿
Influenza virus-infected MDCK cells treated with 10-5 M monensin (MOI = 10) . (A) An infected cell 12 h postinfection,
showing numerous cytoplasmic vesicles that appear empty . Influenza virions are associated with the apical surfaces . x 7,800 . (B)
Higher magnification view of influenza virions budding from the apical membrane in a monensin-treated cell . x 45,000.
treated cells (4, 17). The observed accumulation of VSV par-
ticles in vacuoles may be a result of budding of virus into
cytoplasmic vesicles, as has been observed with Sindbis virus
in the presence of the ionophore (4) . In contrast, influenza
virus-infected cells treated with the same concentrations of
monensin showed numerous virions budding at the free apical
surfaces, as in untreated cells . Dilated cytoplasmic membranes
were also observed in these cells but no influenza virus particles
were found inside these structures. Because the production of
infectious influenza virus requires the presence of two func-
tional glycoproteins, hemagglutinin and neuraminidase, at the
plasma membrane, we conclude that the transport of influenza
virus glycoproteins is insensitive to monensin treatment in
MDCK cells, whereas VSV glycoprotein transport to the cell
surface is impaired by monensin treatment .
A recent report indicates that newly synthesized VSV gly-
coproteins are transported from the endoplasmic reticulum to
the plasma membrane via clathrin-coated vesicles (15) . It is
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possible that monensin blocks exit ofthese coated vesicles from
the Golgi complex . The ionophores are thought to impede
secretion by acting on secretory structures rather than on the
proteins themselves (16) . There is no information as yet on the
composition of structures involved in mediating the transit of
influenza virus glycoproteins to the cell surface, but our results
suggest that these glycoproteins are transported by vesicles
whose formation is insensitive to monensin .
Other viral and cellular membrane proteins also exhibit
polarized distributions in epithelial cells (7, 11) . It will be of
interest to determine whether the differences in response to
monensin observed with VSV and influenza viral glycoproteins
reflect general properties of proteins localized in apical vs.
basolateral membrane domains. The use of ionophores that
selectively block transport of one class ofmembrane proteins
should also aid in elucidating the mechanisms by which mem-
brane glycoproteins are transported from the Golgi complex to
specific cell surface domains .We thankL. R. Melsen forassistance with electron microscopy, M. G.
Roth for providing rhodamine-conjugated rabbit anti-VSV G protein
IgG, andM. W. Shaw for assistance with fluorescence microscopy.
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